1. Home
  2. ONC vs TME Comparison

ONC vs TME Comparison

Compare ONC & TME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONC
  • TME
  • Stock Information
  • Founded
  • ONC 2010
  • TME N/A
  • Country
  • ONC Switzerland
  • TME China
  • Employees
  • ONC N/A
  • TME N/A
  • Industry
  • ONC Biotechnology: Pharmaceutical Preparations
  • TME Broadcasting
  • Sector
  • ONC Health Care
  • TME Consumer Discretionary
  • Exchange
  • ONC Nasdaq
  • TME Nasdaq
  • Market Cap
  • ONC 31.5B
  • TME 33.3B
  • IPO Year
  • ONC N/A
  • TME 2018
  • Fundamental
  • Price
  • ONC $299.01
  • TME $20.54
  • Analyst Decision
  • ONC Strong Buy
  • TME Strong Buy
  • Analyst Count
  • ONC 9
  • TME 6
  • Target Price
  • ONC $332.44
  • TME $15.00
  • AVG Volume (30 Days)
  • ONC 411.4K
  • TME 6.0M
  • Earning Date
  • ONC 08-06-2025
  • TME 08-12-2025
  • Dividend Yield
  • ONC N/A
  • TME 0.88%
  • EPS Growth
  • ONC N/A
  • TME 84.42
  • EPS
  • ONC N/A
  • TME 0.84
  • Revenue
  • ONC $4,175,868,000.00
  • TME $3,994,901,125.00
  • Revenue This Year
  • ONC $865.19
  • TME $11.06
  • Revenue Next Year
  • ONC $21.12
  • TME $11.92
  • P/E Ratio
  • ONC N/A
  • TME $25.04
  • Revenue Growth
  • ONC 51.16
  • TME 5.35
  • 52 Week Low
  • ONC $155.75
  • TME $9.41
  • 52 Week High
  • ONC $308.87
  • TME $22.50
  • Technical
  • Relative Strength Index (RSI)
  • ONC N/A
  • TME 50.86
  • Support Level
  • ONC N/A
  • TME $20.86
  • Resistance Level
  • ONC N/A
  • TME $22.18
  • Average True Range (ATR)
  • ONC 0.00
  • TME 0.64
  • MACD
  • ONC 0.00
  • TME -0.19
  • Stochastic Oscillator
  • ONC 0.00
  • TME 19.67

About ONC BeiGene Ltd. American Depositary Shares

Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeiGene is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeiGene runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeiGene's revenue.

About TME Tencent Music Entertainment Group each representing two

Tencent Music is the largest online music streaming platform in China, established in 2016 through the merger of QQ Music, Kuwo Music, and Kugou Music. Tencent, its largest shareholder, holds over 50% of the shares and more than 90% of the voting rights. Beyond streaming services, Tencent Music generates revenue through a diverse range of offerings, including podcasts, livestreaming, concerts, and karaoke.

Share on Social Networks: